3M (NYSE:MMM) said yesterday that its board of directors nominated CEO Mike Roman as its new chairperson, with current exec chair Inge Thulin announcing their intention to retire. The move is slated to take effect following the St. Paul, Minn.-based company’s annual meeting of shareholders on May 14. “Under Inge’s leadership, 3M evolved into a more […]
Biospace Med
Biospace Med rebrands as Eos Imaging
Biospace Med is changing its name to Eos Imaging, effective immediately, in an effort to capitalize on the name recognition of its flagship low-dose imaging device.
The Paris-based company, which has its U.S. headquarters in Cambridge, Mass., makes a full-body, low-radiation X-ray workstation called the EOS ultra-low-dose 2D/3D orthopedic imaging system.
CEO Marie Meynadier said the re-branding is aimed at leveraging "the tremendous goodwill and name recognition that we have achieved in Europe and North America," according to a press release.
BioSpace Med touts study of its low-dose imaging device
BioSpace Med is touting a small study of its low-dose imaging workstation showing that the EOS 2D/3D device produces better image quality and significantly reduces patients’ radiation exposure.
Biospace Med raises $18 million for market expansion
Biospace Med pulled in $18 million it plans to use to increase its footprint in North America and Europe.
The Paris-based company, which houses its U.S. headquarters in Cambridge, Mass., said it will use the infusion to expand market penetration for its full-body, low-radiation X-ray workstation.
Biospace Med inks European distribution deal
Biospace Med followed up on some good news stateside with a European distribution deal that will see its full-body, low-radiation X-ray workstation hit the market in the Benelux nations.
The Paris, France-based company, which houses its U.S. headquarters in Cambridge, Mass., inked a deal with Oldelft Benelux to distribute its sterEOS 2D/3D X-ray workstation in Belgium, the Netherlands and Luxembourg.
Biospace Med wins FDA clearance for X-ray station
Biospace Med won regulatory clearance to use its full-body, low-radiation X-ray workstation for children with spinal problems.
The Paris, France-based company, which houses its U.S. headquarters in Cambridge, Mass., won 510(k) clearance from the Food & Drug Administration to use its sterEOS 2D/3D workstation in pediatric care.
The device, which consists of a scanner and a three-dimensional bone-modeling program, can capture head-to-toe images of patients in a standing, weight-bearing position, which can help orthopedic surgeons determine balance, posture and the position of each vertebra. The company says the workstation enables better assessments for surgical planning.
